LIF-PTP 300-150-120Recalls & reported problems

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00190376307015), received between Jun 9, 2026 and Jun 9, 2026 — classified as 1 death.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

• DeathJun 9, 2026Adverse Event Without Identified Device or Use Problem

  A PATIENT UNDERWENT A SPINAL PROCEDURE AT L3/4 USING THE LATERAL INTERBODY FUSION PRONE TRANSPOSES (PTP) APPROACH FOR ADJACENT SEGMENT DISEASE ON (B)(6) 2026. NO INTRAOPERATIVE ABNORMALITIES WERE REPORTED, AND THE IMMEDIATE POSTOPERATIVE COURSE WAS INITIALLY STABLE. FOUR DAYS POSTOPERATIVELY, THE PATIENT EXPERIENCED BLEEDING REQUIRING TRANSFUSION, AFTER WHICH THE PATIENT STABILIZED. TWO DAYS LATER, RADIOGRAPHIC IMAGING IDENTIFIED A HEMATOMA NEAR THE SEGMENTAL ARTERY NEAR THE L3/4 LEVEL ON THE LEFT APPROACH SIDE. LATER THAT EVENING, THE PATIENT'S CONDITION DETERIORATED, INCLUDING DEVELOPMENT OF A PSOAS MUSCLE HEMATOMA FOLLOWED BY NON-OCCLUSIVE MESENTERIC ISCHEMIA (NOMI), WHICH WAS TRIGGERED BY HEMORRHAGIC SHOCK. THE PATIENT SUBSEQUENTLY EXPIRED.

  Patient problems: Hematoma; Hemorrhage/Blood Loss/Bleeding

  MAUDE report 25451223 ↗